PLD6
Basic information
Region (hg38): 17:17200995-17206333
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLD6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 16 | 18 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 17 | 3 | 1 |
Variants in PLD6
This is a list of pathogenic ClinVar variants found in the PLD6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-17202772-T-C | not specified | Uncertain significance (Jul 09, 2024) | ||
17-17202834-G-A | not specified | Likely benign (Oct 12, 2022) | ||
17-17202867-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
17-17202904-G-C | not specified | Likely benign (Sep 18, 2024) | ||
17-17202912-A-G | not specified | Uncertain significance (Feb 12, 2024) | ||
17-17202965-G-A | Benign (Apr 16, 2018) | |||
17-17203014-G-A | not specified | Uncertain significance (Mar 12, 2024) | ||
17-17203014-G-C | not specified | Uncertain significance (Feb 13, 2025) | ||
17-17203031-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
17-17203042-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
17-17203056-TG-T | Male infertility | Likely pathogenic (Feb 27, 2023) | ||
17-17205891-G-C | not specified | Uncertain significance (Sep 05, 2024) | ||
17-17205909-G-A | Likely benign (Jul 01, 2022) | |||
17-17205954-C-A | not specified | Uncertain significance (Sep 26, 2023) | ||
17-17205994-A-C | not specified | Uncertain significance (Jun 28, 2024) | ||
17-17206004-C-A | not specified | Uncertain significance (Feb 06, 2024) | ||
17-17206013-C-G | not specified | Uncertain significance (May 30, 2024) | ||
17-17206019-C-G | not specified | Uncertain significance (Feb 27, 2023) | ||
17-17206022-C-T | not specified | Uncertain significance (Mar 22, 2023) | ||
17-17206106-C-G | not specified | Uncertain significance (Feb 15, 2023) | ||
17-17206147-T-C | not specified | Uncertain significance (May 15, 2024) | ||
17-17206193-A-G | not specified | Uncertain significance (Jun 23, 2021) | ||
17-17206286-T-A | Male infertility | Uncertain significance (Feb 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLD6 | protein_coding | protein_coding | ENST00000321560 | 2 | 5321 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00230 | 0.547 | 125166 | 0 | 4 | 125170 | 0.0000160 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.02 | 111 | 146 | 0.761 | 0.00000961 | 1568 |
Missense in Polyphen | 32 | 36.591 | 0.87454 | 405 | ||
Synonymous | 1.08 | 55 | 66.2 | 0.831 | 0.00000476 | 544 |
Loss of Function | 0.243 | 4 | 4.56 | 0.877 | 2.36e-7 | 48 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000179 | 0.0000178 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Endonuclease that plays a critical role in PIWI- interacting RNA (piRNA) biogenesis during spermatogenesis. piRNAs provide essential protection against the activity of mobile genetic elements (By similarity). piRNA-mediated transposon silencing is thus critical for maintaining genome stability, in particular in germline cells when transposons are mobilized as a consequence of wide-spread genomic demethylation (By similarity). Has been proposed to act as a cardiolipin hydrolase to generate phosphatidic acid at mitochondrial surface (By similarity). Although it cannot be excluded that it can act as a phospholipase in some circumstances, it should be noted that cardiolipin hydrolase activity is either undetectable in vitro, or very low (PubMed:21397848). In addition, cardiolipin is almost exclusively found on the inner mitochondrial membrane, while PLD6 localizes to the outer mitochondrial membrane, facing the cytosol (PubMed:21397848). Has been shown to be a backbone-non-specific, single strand-specific nuclease, cleaving either RNA or DNA substrates with similar affinity. Produces 5' phosphate and 3' hydroxyl termini, suggesting it could directly participate in the processing of primary piRNA transcripts (By similarity). Also acts as a regulator of mitochondrial shape through facilitating mitochondrial fusion (PubMed:17028579, PubMed:26711011). {ECO:0000250|UniProtKB:Q5SWZ9, ECO:0000269|PubMed:17028579, ECO:0000269|PubMed:21397848, ECO:0000269|PubMed:26711011}.;
- Pathway
- Gene expression (Transcription);Metabolism of lipids;Metabolism;phospholipases;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PG;Synthesis of PA;PIWI-interacting RNA (piRNA) biogenesis;Gene Silencing by RNA
(Consensus)
Recessive Scores
- pRec
- 0.0997
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.273
- ghis
- 0.600
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.442
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pld6
- Phenotype
- reproductive system phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Gene ontology
- Biological process
- phosphatidic acid biosynthetic process;spermatid development;mitochondrial fusion;positive regulation of mitochondrial fusion;lipid catabolic process;P granule organization;piRNA metabolic process;DNA methylation involved in gamete generation;meiotic cell cycle;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- mitochondrial outer membrane;integral component of membrane
- Molecular function
- endonuclease activity;protein binding;cardiolipin hydrolase activity;protein homodimerization activity;metal ion binding